Mimedx (MDXG) Total Current Liabilities (2010 - 2026)

Mimedx has disclosed Total Current Liabilities across 17 years of filings, most recently posting $38.5 million for Q2 2026.

• In Q2 2026, Total Current Liabilities fell 23.45% year-over-year to $38.5 million; the TTM figure through Jun 2026 stood at $38.5 million (down 23.45% YoY), while the FY2025 annual figure was $64.3 million, up 40.95% from the prior year.
• Total Current Liabilities came in at $38.5 million for Q2 2026 at Mimedx, down from $44.6 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $64.3 million in Q4 2025 to a low of $36.6 million in Q1 2022.
• Average Total Current Liabilities over 5 years is $44.8 million, with a median of $43.6 million recorded in 2022.
• Year-over-year, Total Current Liabilities slumped 33.96% in 2022 and soared 40.95% in 2025.
• Over 5 years, Total Current Liabilities stood at $43.6 million in 2022, then gained by 5.63% to $46.0 million in 2023, then decreased by 0.9% to $45.6 million in 2024, then soared by 40.95% to $64.3 million in 2025, then slumped by 40.1% to $38.5 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $38.5 million in Q2 2026, $44.6 million in Q1 2026, and $64.3 million in Q4 2025.